Multidrug Resistance Protein 4 (MRP4/ABCC4) Protects Cells from the Toxic Effects of Halobenzoquinones

被引:12
|
作者
Li, Jinhua [1 ,2 ]
Bauer, Madlen [1 ]
Moe, Birget [1 ,3 ]
Leslie, Elaine M. [1 ,4 ]
Li, Xing-Fang [1 ]
机构
[1] Univ Alberta, Fac Med & Dent, Dept Lab Med & Pathol, Div Analyt & Environm Toxicol, Edmonton, AB T6G 2G3, Canada
[2] Jilin Univ, Sch Publ Hlth, Changchun 130021, Jilin, Peoples R China
[3] Univ Calgary, Fac Med, Dept Physiol & Pharmacol, Alberta Ctr Toxicol, Calgary, AB T2N 4N1, Canada
[4] Univ Alberta, Fac Med & Dent, Dept Physiol, Edmonton, AB T6G 2H7, Canada
基金
加拿大健康研究院; 加拿大自然科学与工程研究理事会;
关键词
DISINFECTION BY-PRODUCTS; DRINKING-WATER DISINFECTION; OXIDATIVE STRESS; BROMO-BENZOQUINONES; REDUCED GLUTATHIONE; THIOL REACTIVITY; ELIMINATION; TRANSPORTER; COTRANSPORT; ACIDS;
D O I
10.1021/acs.chemrestox.7b00156
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Halobenzoquinones (HBQs) are frequently detected disinfection byproducts (DBPs) in treated water. Recent studies have demonstrated that HBQs are highly cytotoxic and capable of inducing the generation of reactive oxygen species (ROS) and depleting cellular glutathione (GSH). Multidrug resistance proteins (MRPs/ABCCs) are known to play a critical role in the elimination of numerous drugs, carcinogens, toxicants, and their conjugated metabolites. In general, little is known about the roles of transporters in DBP toxicity. Here, we hypothesize that MRPs may play roles in the detoxication of HBQs. To test this hypothesis, we used human embryonic kidney 293 (HEK293) cells stably expressing MRPs (MRP1, 3, 4, and 5) and HEK293 cells with empty vector (HEK-V) to examine the comparative cytotoxicity of four HBQs: 2,6-dichloro-1,4-benzoquinone (2,6-DCBQ), 2,6-dibromo-1,4-benzoquinone (2,6-DBBQ), 2,6-dichloro-3-methyl-1,4-benzoquinone (DCMBQ), and 2,3,6-trichloro-1,4-benzoquinone (TriCBQ). The cytotoxicity (IC50) of the four HBQs in HEK-MRP1, -MRP3, -MRP4, and -MRP5 cells and the control HEK-V cells clearly showed that MRP4 had the most significant effect on reducing the toxicity of the four HBQs. To further support MRP4-mediated detoxication of HBQs, we examined the HBQ-induced ROS levels in HEK-MRP4 and HEK-V cells. ROS levels were significantly reduced in HEK-MRP4 cells compared with HEK-V cells after HBQ treatment. Furthermore, it was found that MRP4-mediated detoxication of the HBQs was GSH dependent, as the cytotoxicity of the HBQs was increased in GSH-depleted HEK-MRP4 cells in comparison to HEK-MRP4 cells. The GSH-dependent protection of cells from HBQs supports the possibility of HBQ-GSH conjugate efflux by MRP4. This study demonstrates a role for MRP4 in cellular protection against HBQ DBP-induced toxicity and oxidative stress.
引用
收藏
页码:1815 / 1822
页数:8
相关论文
共 50 条
  • [31] Multi-drug resistance protein 4 (MRP4/ABCC4) and cyclic nucleotides signaling pathways
    Sassi, Yassine
    Hara, Yannis
    Lompre, Anne-Marie
    Hulot, Jean-Sebastien
    CELL CYCLE, 2009, 8 (07) : 962 - 963
  • [32] Involvement of MRP4 (ABCC4) in the renal excretion of adefovir
    Imaoka, Tomoki
    Kusuhara, Hiroyuki
    Sugiyama, Yuichi
    Adachi, Masashi
    Schuetz, John D.
    DRUG METABOLISM REVIEWS, 2006, 38 : 59 - 60
  • [33] Multidrug Resistance Protein 4 (MRP4/ABCC4) Regulates cAMP Cellular Levels and Controls Human Leukemia Cell Proliferation and Differentiation
    Copsel, Sabrina
    Garcia, Corina
    Diez, Federico
    Vermeulem, Monica
    Baldi, Alberto
    Bianciotti, Liliana G.
    Russel, Frans G. M.
    Shayo, Carina
    Davio, Carlos
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (09) : 6979 - 6988
  • [34] In-vitro characterization of coding variants with predicted functional implications in the efflux transporter multidrug resistance protein 4 (MRP4, ABCC4)
    Mailloux, Jaymie
    Medwid, Samantha
    Facey, Amanda
    Sung, Inmo
    Russell, Laura E.
    Tirona, Rommel G.
    Kim, Richard B.
    Schwarz, Ute, I
    PHARMACOGENETICS AND GENOMICS, 2022, 32 (03): : 111 - 116
  • [35] Functional involvement of multidrug resistance-associated protein 4 (MRP4/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir
    Imaoka, Tomoki
    Kusuhara, Hiroyuki
    Adachi, Masashi
    Schuetz, John D.
    Takeuchi, Kenji
    Sugiyama, Yuichi
    MOLECULAR PHARMACOLOGY, 2007, 71 (02) : 619 - 627
  • [36] Rat multidrug resistance protein 4 (Mrp4, Abcc4): molecular cloning, organ distribution, postnatal renal expression, and chemical inducibility
    Chen, C
    Klaassen, CD
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 317 (01) : 46 - 53
  • [37] Multidrug resistance protein 4 (MRP4/ABCC4) is overexpressed in clear cell renal cell carcinoma (ccRCC) and is essential to regulate cell proliferation
    Melana Colavita, Juan Pablo
    Santiago Todaro, Juan
    de Sousa, Maximiliano
    May, Maria
    Gomez, Natalia
    Yaneff, Agustin
    Di Siervi, Nicolas
    Victoria Aguirre, Maria
    Guijas, Carlos
    Ferrini, Leandro
    Davio, Carlos
    Pablo Rodriguez, Juan
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2020, 161 : 836 - 847
  • [38] Functional characterization of MRP4/ABCC4 protein variants in Xenopus laevis oocytes
    Lang, T.
    Janke, D.
    Mehralivand, S.
    Goedel-Armbrust, U.
    Habermeier, A.
    Gradhand, U.
    Fischer, C.
    Strand, D.
    Toliat, M.
    Klein, K.
    Zanger, U. M.
    Schwab, M.
    Fromm, M. F.
    Closs, E. I.
    Wojnowski, L.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2007, 375 : 103 - 103
  • [39] Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro
    Norris, MD
    Smith, J
    Tanabe, K
    Tobin, P
    Flemming, C
    Scheffer, GL
    Wielinga, L
    Cohn, SL
    London, WB
    Marshall, GM
    Allen, JD
    Haber, M
    MOLECULAR CANCER THERAPEUTICS, 2005, 4 (04) : 547 - 553
  • [40] Release of Platelet-Derived Sphingosine-1-Phosphate Involves Multidrug Resistance Protein 4 (MRP4/ABCC4) and Is Inhibited by Statins
    Vogt, Katja
    Mahajan-Thakur, Shailaja
    Wolf, Robert
    Broderdorf, Susanne
    Vogel, Conny
    Boehm, Andreas
    Ritter, Christoph A.
    Graeler, Markus
    Oswald, Stefan
    Greinacher, Andreas
    Kroemer, Heyo K.
    Jedlitschky, Gabriele
    Rauch, Bernhard H.
    THROMBOSIS AND HAEMOSTASIS, 2018, 118 (01) : 132 - 142